Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1777 to 1826 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 889\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.048\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.053\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03908\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 890\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.048\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 7. [source:swissprot;acc:o15400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.012\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03908\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 891\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.048\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.055\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03907\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 892\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.048\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.055\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03907\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 893\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.048\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.585\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.037\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03903\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 894\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial 60s ribosomal protein l27 (l27mt) (hspc250). [source:swissprot;acc:q9p0m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 231.163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 239.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.042\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03902\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 895\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 155.961\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.039\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent phenylalanine-trna synthetase. [source:refseq;acc:nm\_006567]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03902\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 896\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase ii 13.3 kda polypeptide (ec 2.7.7.6) (rpb11). [source:swissprot;acc:p52435]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 230.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 239.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03888\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent t-cell activation wd repeat protein. [source:refseq;acc:nm\_139281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 243.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.322\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.018\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 897\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-phosphoinositide dependent protein kinase-1 (ec 2.7.1.37) (hpdk1). [source:swissprot;acc:o15530]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 272.878\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 283.472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03882\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent prip-interacting protein pipmt; prip-interacting protein with methyltransferase domain. [source:refseq;acc:nm\_024831]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.878\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.015\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 898\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03874\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pdz/coiled-coil domain binding partner for the rho-family gtpase tc10; fused in glioblastoma; golgi associated pdz and coiled-coil motif containing protein; cftr-associated ligand. [source:refseq;acc:nm\_020399]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.878\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.015\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 899\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 212.027\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.977\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thioredoxin domain-containing 2; sperm-specific thioredoxin; thioredoxin domain-containing 2 (spermatozoa). [source:refseq;acc:nm\_032243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03874\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 900\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.053\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.975\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thioredoxin (atl-derived factor) (adf) (surface associated sulphydryl protein) (sasp). [source:swissprot;acc:p10599]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03874\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 901\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.055\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.973\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 237.62\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 228.762\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03872\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 902\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.055\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.973\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 903\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 4 (eif-3 delta) (eif3 p44) (eif-3 rna-binding subunit) (eif3 p42) (eif3g). [source:swissprot;acc:o75821]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 246.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03849\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent uba/ubx 33.3 kda protein. [source:swissprot;acc:q04323]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.207\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 7.961\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 904\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cirhin; testis expressed gene 292; cirrhosis, autosomal recessive 1a. [source:refseq;acc:nm\_032830]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 243.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.351\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 10 (eif-3 theta) (eif3 p167) (eif3 p180) (eif3 p185) (eif3a). [source:swissprot;acc:q14152]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 246.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03849\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 905\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna directed rna polymerase ii polypeptide j-related gene isoform 3; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_032959]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 230.768\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 239.632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03841\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.207\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.961\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 906\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna directed rna polymerase ii polypeptide j-related gene isoform 1; rpb11b1alpha protein; rpb11b1beta; dna-directed rna polymerase ii subunit 11. [source:refseq;acc:nm\_145325]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.764\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 239.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03838\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent pbk1 protein. [source:sptrembl;acc:o76021]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 243.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.353\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.959\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 907\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent junction plakoglobin (desmoplakin iii). [source:swissprot;acc:p14923]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.653\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03827\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.976\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.017\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.959\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 908\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent sedlin. [source:swissprot;acc:o14582]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 129.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 121.261\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.958\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.653\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03827\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 909\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent septin 1 (larp) (serologically defined breast cancer antigen ny-br- 24). [source:swissprot;acc:q8wyj6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 142.077\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 136.846\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03823\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 129.219\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 121.261\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 7.958\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 910\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent uba/ubx 33.3 kda protein. [source:swissprot;acc:q04323]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 217.168\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 209.207\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03805\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 911\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mannose-p-dolichol utilization defect 1 protein (suppressor of lec15 and lec35 glycosylation mutation homolog) (sl15). [source:swissprot;acc:o75352]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.955\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.94\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 912\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial translational release factor 1-like. [source:refseq;acc:nm\_019041]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 225.939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.013\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.926\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent wd-repeat protein 3. [source:swissprot;acc:q9unx4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 243.896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03803\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 913\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-dependent rna helicase rok1; atp-dependent rna helicase. [source:refseq;acc:nm\_007010]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 243.297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.373\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 7.924\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent prip-interacting protein pipmt; prip-interacting protein with methyltransferase domain. [source:refseq;acc:nm\_024831]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.878\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03801\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/